CAMBRIDGE, Mass., October 01, 2025--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised ...

BOSTON--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced it has raised an oversubscribed $5.2 million seed ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory ...

Predicta is expanding to the US and opening offices in Silicon Valley, the decade-old Brazilian B2B tech company announced today. As you may remember, it first announced these plans last December in ...

Brian McKernan joins as CEO to further advance Predicta’s clinical impact, including its non-invasive diagnostic for Multiple Myeloma “It’s an honor to join Predicta and our strong team of leading ...

In addition to its diagnostic and monitoring platform, Predicta is compiling extensive genomic and transcriptomic data from pre and post treatment timepoints, and using AI to mine the data for novel ...